Insiders · Profile

Peterson Katharine

Chief Accounting Officer at Acrivon Therapeutics. Filing since 18 Aug 2026. CIK 0002022214

Company

Date

Role

Action

Amount

Of holding

18 Aug 2026

Chief Accounting Officer

Sold at will

101

$203.01

0.6%

1 decision on file.